Comera Life Sciences Holdings, Inc. (CMRA): Price and Financial Metrics
GET POWR RATINGS... FREE!
CMRA Stock Price Chart Interactive Chart >
CMRA Price/Volume Stats
| Current price | $1.37 | 52-week high | $11.44 |
| Prev. close | $1.32 | 52-week low | $1.11 |
| Day low | $1.29 | Volume | 17,000 |
| Day high | $1.37 | Avg. volume | 116,217 |
| 50-day MA | $1.40 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 27.19M |
Comera Life Sciences Holdings, Inc. (CMRA) Company Bio
Comera Life Sciences Holdings, Inc. operates as a pre-clinical biotechnology company. It develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. The company's SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. Its products pipeline include CLS-001, an SQ formulation of a marketed, IV administered monoclonal antibody therapeutic for Crohn's disease and ulcerative colitis; CLS-002, an SQ formulation of a marketed, IV-administered immuno-oncology targeted monoclonal antibody for various oncology indications. The company was founded in 2014 and is based in Woburn, Massachusetts.
Latest CMRA News From Around the Web
Below are the latest news stories about COMERA LIFE SCIENCES HOLDINGS INC that investors may wish to consider to help them evaluate CMRA as an investment opportunity.
Comera Life Sciences to Present at 22nd Annual PepTalk ConferenceWOBURN, Mass., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA) (“Company” or “Comera”), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety and convenience, today announced it will present at the 22nd Annual PepTalk Conference, in San Diego on Wednesday, Jan. 18, 2023 at 5:15 p.m. PT. The conference will run from Monday, Jan. 16 through Friday, Jan. 20. Subhashchandra Naik, Ph.D., Senior R |
Comera Life Sciences Holdings Inc. (NASDAQ: CMRA) Is Up 24.09% – Can It Revive?Comera Life Sciences Holdings Inc. (NASDAQ:CMRA) price is hovering higher on Monday, January 09, jumping 24.09% above its previous close. A look at today’s price movement shows that the recent level at last check reads $1.51, with intraday deals fluctuating between $1.17 and $1.58. Taking into account the 52-week price action we note that the … Comera Life Sciences Holdings Inc. (NASDAQ: CMRA) Is Up 24.09% – Can It Revive? Read More » |
Comera Life Sciences to Present at Upcoming Biotech Showcase Investor ConferenceWOBURN, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient delivery, access, safety and convenience, today announced that the company will present at the upcoming Biotech Showcase Conference on Tuesday, January 10, 2023 at 9:00 AM PT in San Francisco, CA. The Company will also host one-on-one meetings with investors from Monday, January 9 through W |
Comera Life Sciences Closes $3.6 Million Private Placement Priced At-the-Market under Nasdaq RulesWOBURN, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, today announced that it has completed a private placement to existing stockholders, of 2,406,242 units, at a purchase price of $1.48 per unit, with each unit consisting of one share of the Company’s common stock and one five-year warrant to purchase two shar |
Comera Life Sciences to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor ConferenceWOBURN, Mass., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. ( Nasdaq: CMRA ), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, today announced it will be participating in the Benchmark Company’s 11 th Annual Discovery One-on-One Investor Conference to be held Thursday, December 1, 2022 at the New York Athletic Club in New York. |
CMRA Price Returns
| 1-mo | -9.57% |
| 3-mo | 13.22% |
| 6-mo | -50.90% |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | 11.38% |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...